GNOM: Global X Genomics & Biotechnology ETF

Performance

GNOM +39.51%

Watchlist

Select an item

RETURNS1DYTD1Y5Y Ann.Max DDSharpeDiv. Yield
GNOM+0.40%+30.44%+39.51%-6.86%-18.67%1.011.10%

Summary

GNOM at a glance

GNOM returned +39.51% over the past year and -6.86% a year over five years. Its worst drop in that year was -18.67%, smaller than 29% of ETFs on Redstone, and its Sharpe ratio of 1.01 beats 87% of ETFs on Redstone. It yields 1.10%.

Current Drawdown

-18.34%

Rolling Volatility

52.17%

Dividends

GNOM dividends

Yield

1.10%

Paid, past year

$0.65

Pays

Twice a year

Growth a year

—

Per share, by year

2025
$0.31
Past year
$0.65

Yearly return over 5 years

With dividends-6.86%
Price only-7.14%
From dividends+0.28 pts

GNOM paid $0.65 a share over the past year, twice a year. With dividends reinvested it returned -6.86% a year over five years, against -7.14% on price alone.

›All 4 payments since Dec 30, 2021
  • Jun 29, 2026$0.0579
  • Dec 30, 2025$0.5912
  • Jun 27, 2025$0.0331
  • Dec 30, 2021$0.026
Actions

Metrics

Risk Indicators

Alpha23.99%
Beta1.42x
Sharpe1.01
Sortino1.58
Omega1.19
Calmar2.12
Martin4.88

Profile

About GNOM

The Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.

From its prospectus, filed Mar 31, 2026
Category
Health Care
Expense ratio
0.50%
Fund size
$110M
Inception
Apr 2019